Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $1.7M | 3 | 84.4% |
| Acquisitions | $274,207 | 1 | 13.8% |
| Consulting Fee | $33,327 | 6 | 1.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,000 | 1 | 0.2% |
| Food and Beverage | $399.12 | 10 | 0.0% |
| Unspecified | $0 | 13 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Anika Therapeutics, Inc. | $2.0M | 4 | $0 (2021) |
| Primo Medical Group, Inc. (f.k.a. STD Med Inc.) | $36,327 | 7 | $0 (2024) |
| Spirus Medical LLC | $138.66 | 1 | $0 (2019) |
| Stryker Corporation | $101.82 | 2 | $0 (2019) |
| Arthrosurface Incorporated | $45.12 | 4 | $0 (2019) |
| DePuy Synthes Sales Inc. | $41.50 | 2 | $0 (2017) |
| Ethicon US, LLC | $37.56 | 1 | $0 (2018) |
| Bioventus LLC | $20.34 | 1 | $0 (2017) |
| Genentech USA, Inc. | $14.11 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,792 | 1 | Primo Medical Group, Inc. (f.k.a. STD Med Inc.) ($23,792) |
| 2022 | $1,500 | 2 | Primo Medical Group, Inc. (f.k.a. STD Med Inc.) ($1,500) |
| 2021 | $277,207 | 3 | Anika Therapeutics, Inc. ($274,207) |
| 2020 | $1.7M | 7 | Anika Therapeutics, Inc. ($1.7M) |
| 2019 | $1,731 | 7 | Primo Medical Group, Inc. (f.k.a. STD Med Inc.) ($1,500) |
| 2018 | $1,583 | 6 | Primo Medical Group, Inc. (f.k.a. STD Med Inc.) ($1,500) |
| 2017 | $2,785 | 8 | Primo Medical Group, Inc. (f.k.a. STD Med Inc.) ($2,700) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Primo Medical Group, Inc. (f.k.a. STD Med Inc.) | — | Consulting Fee | Cash or cash equivalent | $23,792.00 | General |
| 05/23/2022 | Primo Medical Group, Inc. (f.k.a. STD Med Inc.) | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 2022 | Cardiosolutions, Inc. | — | — | — | $0.00 | Ownership |
| 07/09/2021 | Anika Therapeutics, Inc. | — | Acquisitions | Cash or cash equivalent | $274,207.45 | General |
| 04/13/2021 | Primo Medical Group, Inc. (f.k.a. STD Med Inc.) | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| 2021 | Cardiosolutions, Inc. | — | — | — | $0.00 | Ownership |
| 10/27/2020 | Anika Therapeutics, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $137,889.87 | General |
| 08/15/2020 | Cardiosolutions, Inc. | — | Food and Beverage | In-kind items and services | $0.01 | General |
| 05/11/2020 | Anika Therapeutics, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $12,233.44 | General |
| 02/03/2020 | Anika Therapeutics, Inc. | — | Current or prospective ownership or investment interest | Cash or cash equivalent | $1,528,837.46 | General |
| 01/31/2020 | Primo Medical Group, Inc. (f.k.a. STD Med Inc.) | — | Consulting Fee | Cash or cash equivalent | $2,335.00 | General |
| 2020 | Cardiosolutions, Inc. | — | — | — | $0.00 | Ownership |
| 2020 | Saphena Medical, Inc. | — | — | — | $0.00 | Ownership |
| 11/05/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Virology & Specialty Care | ||||||
| 10/30/2019 | Stryker Corporation | TRAUMA (Device) | Food and Beverage | Cash or cash equivalent | $78.68 | General |
| Category: STRETCHERS | ||||||
| 06/11/2019 | Primo Medical Group, Inc. (f.k.a. STD Med Inc.) | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 04/09/2019 | Spirus Medical LLC | — | Food and Beverage | Cash or cash equivalent | $138.66 | General |
| 2019 | Arthrosurface Incorporated | — | — | — | $0.00 | Ownership |
| 2019 | Saphena Medical, Inc. | — | — | — | $0.00 | Ownership |
| 2019 | Cardiosolutions, Inc. | — | — | — | $0.00 | Ownership |
| 11/20/2018 | Arthrosurface Incorporated | HemiCAP Shoulder (Device) | Food and Beverage | In-kind items and services | $45.12 | General |
| Category: Musculoskeletal | ||||||
| 06/26/2018 | Ethicon US, LLC | DERMABOND Portfolio (Device), STRATAFIX | Food and Beverage | In-kind items and services | $37.56 | General |
| Category: Wound Closure | ||||||
| 01/10/2018 | Primo Medical Group, Inc. (f.k.a. STD Med Inc.) | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 2018 | Arthrosurface Incorporated | — | — | — | $0.00 | Ownership |
| 2018 | Saphena Medical, Inc. | — | — | — | $0.00 | Ownership |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 730 | 2,842 | $169,544 | $44,748 |
| 2022 | 15 | 1,122 | 4,102 | $287,543 | $87,901 |
| 2021 | 16 | 1,228 | 4,431 | $282,037 | $87,119 |
| 2020 | 14 | 1,177 | 4,599 | $281,006 | $88,020 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 106 | 239 | $53,775 | $11,436 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 160 | $23,310 | $9,598 | 41.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 103 | 214 | $20,544 | $8,582 | 41.8% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 144 | 246 | $20,910 | $6,179 | 29.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $8,640 | $2,824 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 23 | $4,485 | $2,023 | 45.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 116 | 1,819 | $27,270 | $1,431 | 5.2% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 11 | 23 | $3,910 | $755.65 | 19.3% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 22 | 26 | $2,340 | $716.75 | 30.6% |
| 73100 | X-ray of wrist, 2 views | Office | 2023 | 12 | 20 | $1,700 | $482.37 | 28.4% |
| 73501 | X-ray of hip, 1 view | Office | 2023 | 17 | 20 | $1,300 | $409.35 | 31.5% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 11 | 16 | $1,360 | $310.58 | 22.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 154 | 360 | $81,000 | $18,249 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 194 | 292 | $42,632 | $17,913 | 42.0% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2022 | 14 | 105 | $19,347 | $10,878 | 56.2% |
| 73560 | X-ray of knee, 1-2 views | Office | 2022 | 196 | 331 | $28,730 | $8,273 | 28.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 106 | 179 | $17,234 | $8,224 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 85 | $16,610 | $7,841 | 47.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 56 | 56 | $13,440 | $4,991 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $11,100 | $4,174 | 37.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 173 | 2,475 | $37,125 | $2,123 | 5.7% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 33 | 56 | $5,040 | $1,469 | 29.2% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2022 | 18 | 27 | $4,590 | $970.91 | 21.2% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2022 | 14 | 20 | $4,480 | $821.41 | 18.3% |
| 73100 | X-ray of wrist, 2 views | Office | 2022 | 18 | 33 | $2,805 | $809.02 | 28.8% |
About Dr. Anthony Buonanno, M.D
Dr. Anthony Buonanno, M.D is a Orthopaedic Surgery healthcare provider based in Johnston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831157759.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Buonanno, M.D has received a total of $2.0M in payments from pharmaceutical and medical device companies, with $23,792 received in 2024. These payments were reported across 34 transactions from 11 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($1.7M).
As a Medicare-enrolled provider, Buonanno has provided services to 4,257 Medicare beneficiaries, totaling 15,974 services with total Medicare billing of $307,789. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Location Johnston, RI
- Active Since 05/02/2006
- Last Updated 04/08/2009
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1831157759
Products in Payments
- TRAUMA (Device) $78.68
- HemiCAP Shoulder (Device) $45.12
- ORTHOVISC (Device) $41.50
- DERMABOND Portfolio (Device) $37.56
- Makoplasty (Device) $23.14
- Exogen (Device) $20.34
- Xofluza (Drug) $14.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.